BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations
Open Access
- 4 May 2015
- journal article
- clinical trial
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 125 (6), 2363-2368
- https://doi.org/10.1172/jci81163
Abstract
A transition from fetal hemoglobin (HbF) to adult hemoglobin (HbA) normally occurs within a few months after birth. Increased production of HbF after this period of infancy ameliorates clinical symptoms of the major disorders of adult β-hemoglobin: β-thalassemia and sickle cell disease. The transcription factor BCL11A silences HbF and has been an attractive therapeutic target for increasing HbF levels; however, it is not clear to what extent BCL11A inhibits HbF production or mediates other developmental functions in humans. Here, we identified and characterized 3 patients with rare microdeletions of 2p15-p16.1 who presented with an autism spectrum disorder and developmental delay. Moreover, these patients all exhibited substantial persistence of HbF but otherwise retained apparently normal hematologic and immunologic function. Of the genes within 2p15-p16.1, only BCL11A was commonly deleted in all of the patients. Evaluation of gene expression data sets from developing and adult human brains revealed that BCL11A expression patterns are similar to other genes associated with neurodevelopmental disorders. Additionally, common SNPs within the second intron of BCL11A are strongly associated with schizophrenia. Together, the study of these rare patients and orthogonal genetic data demonstrates that BCL11A plays a central role in silencing HbF in humans and implicates BCL11A as an important factor for neurodevelopment.This publication has 24 references indexed in Scilit:
- Genome‐wide association study in German patients with attention deficit/hyperactivity disorderNeuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG), 2011
- A Functional Element Necessary for Fetal Hemoglobin SilencingThe New England Journal of Medicine, 2011
- Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAsBlood, 2010
- Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation.Nature Genetics, 2010
- Developmental and species-divergent globin switching are driven by BCL11ANature, 2009
- Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11AScience, 2008
- The facial dysmorphy in the newly recognised microdeletion 2p15-p16.1 refined to a 570 kb region in 2p15Journal of Medical Genetics, 2007
- Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1Journal of Medical Genetics, 2007
- Control of globin gene expression during development and erythroid differentiationExperimental Hematology, 2005
- A Novel Nuclear Human Poly(A) Polymerase (PAP), PAPγOnline Journal of Public Health Informatics, 2001